GB00B89J2419 - A1J440 (XLON)
CLINIGEN GROUP PLC LS-001 Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | - | - | - |
Firmenprofil zu CLINIGEN GROUP PLC LS-001 Aktie
Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.
Investierte Fonds
Folgende Fonds haben in CLINIGEN GROUP PLC LS-001 investiert:
Fonds | Vol. in Mio 1.081,40 | Anteil (%) 0,18 % |
Unternehmensdaten zur CLINIGEN GROUP PLC LS-001 Aktie
Name CLINIGEN GROUP PLC LS-001
Firma Clinigen Group plc
Website https://www.clinigengroup.com
Heimatbörse
London
WKN A1J440
ISIN GB00B89J2419
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Distribution
CEO Mr. Shaun Chilton
Land Großbritannien und Nordirland
Währung GBP
Mitarbeiter 1,0 T
Adresse Pitcairn House, Crown Square, First Avenue, DE14 2WW STAFFORDSHIRE
IPO Datum 2012-09-25
Dividenden von CLINIGEN GROUP PLC LS-001
Ex-Datum | Dividende pro Aktie |
---|---|
02.12.2021 | 5,46 GBX |
18.03.2021 | 2,15 GBX |
05.11.2020 | 5,46 GBX |
19.03.2020 | 2,15 GBX |
07.11.2019 | 4,75 GBX |
21.03.2019 | 1,95 GBX |
08.11.2018 | 3,84 GBX |
22.03.2018 | 1,76 GBX |
09.11.2017 | 3,40 GBX |
23.03.2017 | 1,60 GBX |
Ticker Symbole
Name | Symbol |
---|---|
London | CLIN.L |
Weitere Aktien
Investoren die CLINIGEN GROUP PLC LS-001 halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024